Standard Biotools (LAB) Total Debt (QoQ) (2011 - 2024)
Powered by 
Analysis
Standard Biotools (LAB) Total Debt (QoQ) (2011 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.64 Bn | 221.57 Bn | 8.34 Bn |
| 2 | Danaher | 144.47 Bn | 140.12 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 40.90 Bn | 39.15 Bn | 1.04 Bn |
| 4 | Illumina | 30.90 Bn | 29.73 Bn | 770.00 Mn |
| 5 | Revvity | 13.85 Bn | 12.82 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.27 Bn | 11.00 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.12 Bn | 8.50 Bn | 345.80 Mn |
| 8 | Repligen | 9.28 Bn | 8.27 Bn | 110.04 Mn |
| 9 | 10x Genomics | 8.70 Bn | 8.14 Bn | 112.50 Mn |
| 10 | Standard Biotools | 282.88 Mn | -193.84 Mn | 10.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 0.24% |
| Jun 30, 2024 | 0.23% |
| Mar 31, 2024 | -5.67% |
| Dec 31, 2023 | 502.64% |
| Sep 30, 2023 | -86.23% |
| Jun 30, 2023 | 575.71% |
| Mar 31, 2023 | 0.55% |
| Dec 31, 2022 | 0.57% |
| Sep 30, 2022 | 0.56% |
| Jun 30, 2022 | 0.55% |
| Mar 31, 2022 | -40.16% |
| Dec 31, 2021 | 68.87% |
| Sep 30, 2012 | -33.70% |
| Jun 30, 2012 | -55.42% |
| Mar 31, 2012 | -37.43% |
| Dec 31, 2011 | -12.53% |
| Sep 30, 2011 | -10.89% |
| Jun 30, 2011 | 364.50% |
| Mar 31, 2011 | -80.95% |